Avandia, a drug used to treat Type 2 diabetes, is again becoming a controversial drug for the FDA. The FDA announced last week that the drug will begin to carry a “black box” warning on its label. A black box warning is the strongest warning that a drug can be forced to carry. Since May, Avandia has been the subject of strong criticism. In May, a New England Journal of Medicine found a 43 percent increase in the risk of heart attack compared to a control group.
For the full article.